Skip to content

Efficacy of children with cleft palate undergoing palatoplasty under General Anesthesia

Comparing the efficacy of sphenopalatine ganglion block with palatal block for analgesia in children with cleft palate undergoing palatoplasty under General Anesthesia : A Randomized control study - NA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061203
Enrollment
50
Registered
2024-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q378- Unspecified cleft palate with bilateral cleft lip

Interventions

Intervention1: sphenopalatine ganglion block in children undergoing palatoplasty : dose- 0.25% ropivacaine (less than 2ml/kg bodyweight) route of administration- local infiltration submucosally freque

Sponsors

Department of Anaesthesiology and Intensive Care Unit
Lead Sponsor
Operation Theater
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: ASA grade I and II patients. Pediatric patients of age 1-5 years All patients/ guardian giving written informed consent will be taken All cleft palate patients

Exclusion criteria

Exclusion criteria: Patient/guardian not willing to participate in the study Children who had an allergy to local anesthetics, any coagulation disorder, local infection concomitant rhinoplasty, any additional congenital anomalies,

Design outcomes

Primary

MeasureTime frame
To compare effectiveness of sphenopalatine ganglion block vs palatal block on postoperative analgesia following palatoplasty using FLACC scoreTimepoint: 48 to 72hrs

Secondary

MeasureTime frame
To compare the following criteria in both groups- need of rescue analgesia parental satisfaction using likert scale. Intraoperative hemodynamics Timepoint: 48 hrs

Countries

India

Contacts

Public ContactDr Manish Singh

King Georges Medical University Lucknow

manish.is.singh34@gmail.com9453625852

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026